Abbott noted that the Amplatzer Piccolo, a device even smaller than a small pea, now offers hope to premature infants and newborns who need corrective treatment, and who may be non-responsive to ...

Abbott has received an innovation award for Lingo, its first consumer biowearable over-the-counter device designed to support ...

Abbott Laboratories ABT announced receiving approvals for two life-saving pediatric devices — the Masters HP 15mm rotatable mechanical heart valve and the Amplatzer Piccolo Occluder — in Europe.

Abbott Laboratories ABT announced receiving approvals for two life-saving pediatric devices — the Masters HP 15mm rotatable mechanical heart valve and the Amplatzer Piccolo Occluder — in Europe.

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event ...

Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...

Abbott Laboratories’ Piccolo will be one of the smallest-ever heart devices. ... Abbott Laboratories' Piccolo heart device, used to close holes in the hearts of some premature infants.

The Piccolo device joins Abbott's family of Amplatzer Occluder therapies, including the already approved Duct Occluder II for treating PDA in larger pediatric patients.

ABBOTT PARK, Ill., Sept. 8, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced three-year data showing the positive impact of the Amplatzer Piccolo™ Occluder on treating babies (some ...